Description:
This CDC developed invention pertains to
Streptococcus pneumoniae protein "pneumococcal fimbrial protein A (PfpA)," as well as the encoding
pfpA gene.
S. pneumoniae linked pneumococcal disease is prevalent among the very young, the elderly and also immunocompromised individuals. This invention covers the breadth of directly PfpA-related technology that might be employed for development of diagnostic tests for
S. pneumoniae and/or vaccines directed against the pathogen. In addition to the the intellectual property protected amino acid sequence and encoding plasmid, monoclonal antibodies and corresponding hybridomas are also available.